Hyaluronic Acid Based Hydrogels Attenuate Inflammatory Receptors and Neurotrophins in Interleukin-1β Induced Inflammation Model of Nucleus Pulposus Cells.

Inflammation plays an important role in symptomatic intervertebral disc degeneration and is associated with the production of neurotrophins in sensitizing innervation into the disc. The use of high molecular weight (HMw) hyaluronic acid (HA) hydrogels offers a potential therapeutic biomaterial for nucleus pulposus (NP) regeneration as it exerts an anti-inflammatory effect and provides a microenvironment that is more suitable for NP. Therefore, it was hypothesized that cross-linked HMw HA hydrogels modulate the inflammatory receptor of IL-1R1, MyD88 and neurotrophin expression of nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) in an in vitro inflammation model of NP. HA cross-linking was optimized using various concentrations of 4-arm PEG-amine by determination of free carboxyl groups of HA and unreacted free amine groups of PEG-amine. The optimally cross-linked HA hydrogels were characterized for hydrolytic stability, enzymatic degradation and cytotoxicity on NP cells. The therapeutic effect of HA hydrogels was further investigated in IL-1β induced inflammation on NP cell cultures and the mechanism of HA by examining the expression of cell surface receptor of CD44. Hydrogel was optimally cross-linked at 75 mM PEG, stable in phosphate buffered saline, and showed greater than 40% resistance to enzymatic degradation. No cytotoxic effect of NP cells was observed in the presence of hydrogels for 1, 3, and 7 days. IL-1R1 and MyD88 were significantly suppressed. Additionally, NGF and BDNF mRNA were down-regulated after treatment with cross-linked HA hydrogel. Possible protective mechanism of HA is shown by high expression of CD44 receptor of NP cells after HA treatment in which suggest the binding of HA to CD44 receptor and prevent NP cells from further undergoing inflammation. These results indicate that optimally stabilized cross-linked HMw HA hydrogel has a therapeutic effect in response to inflammation-associated pain and becomes an ideal matrices hydrogel for NP regeneration.

[1]  J. Bendo,et al.  Adjacent segment degeneration following spinal fusion for degenerative disc disease. , 2007, Bulletin of the NYU hospital for joint diseases.

[2]  François Berthod,et al.  In vitro development of a tissue‐engineered model of peripheral nerve regeneration to study neurite growth , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[3]  Roger Chou,et al.  Medications for Acute and Chronic Low Back Pain: A Review of the Evidence for an American Pain Society/American College of Physicians Clinical Practice Guideline , 2007, Annals of Internal Medicine.

[4]  Pierre Weiss,et al.  An injectable vehicle for nucleus pulposus cell-based therapy. , 2011, Biomaterials.

[5]  A. Pandit,et al.  Three-Dimensional Microgel Platform for the Production of Cell Factories Tailored for the Nucleus Pulposus. , 2015, Bioconjugate chemistry.

[6]  P. Herrlich,et al.  CD44: From adhesion molecules to signalling regulators , 2003, Nature Reviews Molecular Cell Biology.

[7]  P. Croft,et al.  Epidemiology and natural history of low back pain. , 2004, Europa medicophysica.

[8]  A. Spicer,et al.  Hyaluronan: a multifunctional, megaDalton, stealth molecule. , 2000, Current opinion in cell biology.

[9]  C. Henke,et al.  Acute lung injury fibroblast migration and invasion of a fibrin matrix is mediated by CD44. , 1996, The Journal of clinical investigation.

[10]  S. Ohtori,et al.  Resolving discogenic pain , 2008, European Spine Journal.

[11]  C. A. de la Motte,et al.  Hyaluronan cross-linking: a protective mechanism in inflammation? , 2005, Trends in immunology.

[12]  Robert Stern,et al.  Hyaluronan fragments: an information-rich system. , 2006, European journal of cell biology.

[13]  H. Gruber,et al.  Brain-derived neurotrophic factor and its receptor in the human and the sand rat intervertebral disc , 2008, Arthritis research & therapy.

[14]  L Punnett,et al.  The global burden of occupationally related low back pain: estimates from the Global Burden of Disease 2010 study , 2014, Annals of the rheumatic diseases.

[15]  R. Dai,et al.  Brain derived neurotrophic factor (BDNF) contributes to the pain hypersensitivity following surgical incision in the rats , 2008, Molecular pain.

[16]  S. Goldman,et al.  Brain-derived neurotrophic factor promotes the survival of neurons arising from the adult rat forebrain subependymal zone. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[17]  A. Freemont,et al.  Investigation of the role of IL-1 and TNF in matrix degradation in the intervertebral disc. , 2008, Rheumatology.

[18]  D. Nance,et al.  Migration of bovine aortic smooth muscle cells after wounding injury. The role of hyaluronan and RHAMM. , 1995, The Journal of clinical investigation.

[19]  S. Abram,et al.  Anatomy and pathophysiology of intervertebral disc disease , 2009 .

[20]  N. Boos,et al.  Inflammatory and catabolic signalling in intervertebral discs: the roles of NF-κB and MAP kinases. , 2012, European cells & materials.

[21]  M. Alini,et al.  An injectable cross-linked scaffold for nucleus pulposus regeneration. , 2008, Biomaterials.

[22]  C. C. Leitch,et al.  In vivo evidence that truncated trkB.T1 participates in nociception , 2009, Molecular pain.

[23]  A. Freemont,et al.  The role of interleukin-1 in the pathogenesis of human Intervertebral disc degeneration , 2005, Arthritis research & therapy.

[24]  J. Forrester,et al.  Inhibition of phagocytosis by high molecular weight hyaluronate. , 1980, Immunology.

[25]  D. Rosenzweig,et al.  Painful, degenerating intervertebral discs up-regulate neurite sprouting and CGRP through nociceptive factors , 2014, Journal of cellular and molecular medicine.

[26]  E. Karna,et al.  Hyaluronic acid counteracts interleukin-1-induced inhibition of collagen biosynthesis in cultured human chondrocytes. , 2006, Pharmacological research.

[27]  R. Cortivo,et al.  Hyaluronic Acid Induces Activation of the κ-Opioid Receptor , 2013, PloS one.

[28]  J. Rubin,et al.  Novel multiarm PEG-based hydrogels for tissue engineering. , 2009, Journal of biomedical materials research. Part A.

[29]  S. McMahon,et al.  Tackling Pain at the Source: New Ideas about Nociceptors , 1998, Neuron.

[30]  H. An,et al.  Proinflammatory Cytokines Stimulate the Expression of Nerve Growth Factor by Human Intervertebral Disc Cells , 2007, Spine.

[31]  L. Lossi,et al.  BDNF as a pain modulator , 2008, Progress in Neurobiology.

[32]  Samuel K. Cho,et al.  Intact glycosaminoglycans from intervertebral disc-derived notochordal cell-conditioned media inhibit neurite growth while maintaining neuronal cell viability. , 2015, The spine journal : official journal of the North American Spine Society.

[33]  Karin Wuertz,et al.  Inflammatory Mediators in Intervertebral Disk Degeneration and Discogenic Pain , 2013, Global spine journal.

[34]  石田 治.  Chondrocytes are regulated by cellular adhesion through CD44 and hyaluronic acid pathway , 1997 .

[35]  R. Geary,et al.  Hyaluronan Enhances Contraction of Collagen by Smooth Muscle Cells and Adventitial Fibroblasts: Role of CD44 and Implications for Constrictive Remodeling , 2001, Circulation research.

[36]  Justin J Cooper-White,et al.  An injectable hydrogel incorporating mesenchymal precursor cells and pentosan polysulphate for intervertebral disc regeneration. , 2013, Biomaterials.

[37]  H. Defino,et al.  Cytokine inhibition and time-related influence of inflammatory stimuli on the hyperalgesia induced by the nucleus pulposus , 2012, European Spine Journal.

[38]  C. Kepler,et al.  The molecular basis of intervertebral disc degeneration. , 2013, The spine journal : official journal of the North American Spine Society.

[39]  Bernd Fritzsch,et al.  Cranial sensory neuron development in the absence of brain-derived neurotrophic factor in BDNF/Bax double null mice. , 2004, Developmental biology.

[40]  M. Dougados,et al.  High molecular weight sodium hyaluronate (hyalectin) in osteoarthritis of the knee: a 1 year placebo-controlled trial. , 1993, Osteoarthritis and cartilage.

[41]  M. Alini,et al.  Thermoreversible hyaluronan-based hydrogel supports in vitro and ex vivo disc-like differentiation of human mesenchymal stem cells. , 2013, The spine journal : official journal of the North American Spine Society.

[42]  Haeyoun Kang,et al.  Interleukin‐1β induces angiogenesis and innervation in human intervertebral disc degeneration , 2011, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[43]  R. Ravazzolo,et al.  Induction of RET Dependent and Independent Pro-Inflammatory Programs in Human Peripheral Blood Mononuclear Cells from Hirschsprung Patients , 2013, PloS one.

[44]  U. Schumacher,et al.  Inhibition of hyaluronan export from human fibroblasts by inhibitors of multidrug resistance transporters. , 2004, Biochemical pharmacology.

[45]  M. Holmes,et al.  Evidence that endogenous beta nerve growth factor is responsible for the collateral sprouting, but not the regeneration, of nociceptive axons in adult rats. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[46]  C. A. de la Motte,et al.  Hyaluronan, a Crucial Regulator of Inflammation , 2014, Front. Immunol..

[47]  P. Prehm.  Hyaluronate is synthesized at plasma membranes. , 1984, The Biochemical journal.

[48]  A. Freemont,et al.  Nerve growth factor expression and innervation of the painful intervertebral disc , 2002, The Journal of pathology.

[49]  M. Jayson,et al.  Nerve ingrowth into diseased intervertebral disc in chronic back pain , 1997, The Lancet.

[50]  W. Akeson,et al.  High-molecular-weight hyaluronan inhibits macrophage proliferation and cytokine release in the early wound of a preclinical postlaminectomy rat model. , 2006, The spine journal : official journal of the North American Spine Society.

[51]  K. Ando,et al.  Regenerative effects of transplanting mesenchymal stem cells embedded in atelocollagen to the degenerated intervertebral disc. , 2006, Biomaterials.

[52]  Yung-Yang Liu,et al.  High-molecular-weight hyaluronan – a possible new treatment for sepsis-induced lung injury: a preclinical study in mechanically ventilated rats , 2008, Critical care.

[53]  Xiaobing Fu,et al.  Possible Pathogenesis of Painful Intervertebral Disc Degeneration , 2006, Spine.

[54]  Lonnie D Shea,et al.  Non-viral vector delivery from PEG-hyaluronic acid hydrogels. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[55]  M. Lenz,et al.  Axonal Growth Potential of Lumbar Dorsal Root Ganglion Neurons in an Organ Culture System: Response of Nerve Growth Factor-sensitive Neurons to Neuronal Injury and an Inflammatory Cytokine , 2007, Spine.

[56]  E Viikari-Juntura,et al.  Low back pain in relation to lumbar disc degeneration. , 2000, Spine.

[57]  C. A. de la Motte,et al.  Copyright © American Society for Investigative Pathology Mononuclear Leukocytes Bind to Specific Hyaluronan Structures on Colon Mucosal Smooth Muscle Cells Treated with Polyinosinic Acid:Polycytidylic Acid Inter-�-Trypsin Inhibitor Is Crucial to Structure , 2022 .

[58]  C. Woolf,et al.  Peripheral cell types contributing to the hyperalgesic action of nerve growth factor in inflammation , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[59]  A. Freemont,et al.  Catabolic cytokine expression in degenerate and herniated human intervertebral discs: IL-1β and TNFα expression profile , 2007, Arthritis research & therapy.

[60]  Ricardo Pietrobon,et al.  Prescription of nonsteroidal anti-inflammatory drugs and muscle relaxants for back pain in the United States. , 2004, Spine.

[61]  S. Ohtori,et al.  Distribution and immunocytochemical characterization of dorsal root ganglion neurons innervating the lumbar intervertebral disc in rats: a review. , 2004, Life sciences.